{
    "clinical_study": {
        "@rank": "48536", 
        "arm_group": [
            {
                "arm_group_label": "Ketamine", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects in the ketamine arm will receive ketamine for sedation prior to rapid sequence intubation (RSI)."
            }, 
            {
                "arm_group_label": "Etomidate", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects in the etomidate arm will receive etomidate for sedation prior to rapid sequence intubation (RSI)."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the effectiveness and safety of ketamine and\n      etomidate during rapid sequence intubation (RSI)."
        }, 
        "brief_title": "Ketamine Versus Etomidate for Rapid Sequence Intubation", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Airway Control", 
            "Anesthesia", 
            "Intubation", 
            "Complication"
        ], 
        "detailed_description": {
            "textblock": "This study is a randomized controlled trial of etomidate versus ketamine during rapid\n      sequence intubation (RSI).  RSI refers to the process by which patients who require\n      emergency airway management undergo sedation and paralysis prior to insertion of an\n      endotracheal tube(airway tube).  Patients who require intubation will be randomized to have\n      intubation performed with either ketamine or etomidate.  All other care will be at the\n      discretion of the treating physicians.  The purpose of this study is to compare the efficacy\n      and safety of ketamine and etomidate during rapid sequence intubation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age\n\n          -  Undergoing rapid sequence intubation (RSI) in the Emergency Department\n\n        Exclusion Criteria:\n\n          -  Known contraindication to ketamine or etomidate\n\n          -  Patient declines participation in the trial by wearing a bracelet marked \"KvE\n             declined\"\n\n          -  Prisoner"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01823328", 
            "org_study_id": "HSR 13-3601"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ketamine", 
                "description": "Subjects will receive ketamine for sedation prior to rapid sequence intubation.", 
                "intervention_name": "Ketamine", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Ketanest", 
                    "Ketaset", 
                    "Ketalar"
                ]
            }, 
            {
                "arm_group_label": "Etomidate", 
                "description": "Subjects will receive etomidate for sedation prior to rapid sequence intubation.", 
                "intervention_name": "Etomidate", 
                "intervention_type": "Drug", 
                "other_name": "Amidate"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ketamine", 
                "Etomidate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Intubation", 
            "Airway", 
            "Emergent intubation", 
            "Rapid sequence intubation", 
            "Rapid sequence induction", 
            "RSI", 
            "Ketamine", 
            "Etomidate", 
            "Sepsis", 
            "Sedative", 
            "Sedation"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "link": {
            "description": "Public description of study protocol.", 
            "url": "http://hcmced.org/airway.html"
        }, 
        "location": {
            "contact": {
                "email": "miner015@umn.edu", 
                "last_name": "James R Miner, MD", 
                "phone": "612-873-8791"
            }, 
            "facility": {
                "address": {
                    "city": "Minneapolis", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55415"
                }, 
                "name": "Hennepin County Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "James R Miner, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Johanna C Moore, MD, MPH", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Brian E Driver, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Robert F Reardon, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Ketamine Versus Etomidate for Sedation of Emergency Department Patients During Rapid Sequence Intubation", 
        "overall_contact": {
            "email": "research.hcmed@gmail.com", 
            "last_name": "Lila Steinberg, BA", 
            "phone": "612-873-9528"
        }, 
        "overall_official": {
            "affiliation": "Hennepin County Medical Canter", 
            "last_name": "Brian E Driver, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Mortality will be assessed at 30 days or at discharge from the hospital, whichever occurs first. This study is not powered to detect a significant difference in mortality, however; this will primarily be a safety study comparing the use ketamine versus etomidate as sedative agents for rapid sequence intubation (RSI) in the Emergency Department (ED).", 
            "measure": "Mortality", 
            "safety_issue": "Yes", 
            "time_frame": "30 Days or Discharge"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01823328"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluate mortality for the sub-group diagnosed with sepsis and septic shock, defined as:\n- Suspected infection, and at least 2 of 4 systemic inflammatory response syndrome (SIRS) criteria:\nTemperature >38C or <36C\nRespiratory Rate >20 or PaCO2 <32 mmHg\nHeart Rate >90\nWhite blood cell count >12,000 or <4,000, or > 10% bands\nSeptic shock:\ndefined as sepsis plus either: 1) Systolic blood pressure <90 after 1L of intravenous fluid or 2) lactate >=4mmol/L", 
                "measure": "Mortality in Sepsis and Septic Shock", 
                "safety_issue": "Yes", 
                "time_frame": "30 Days"
            }, 
            {
                "description": "The rate of first pass success, defined as successful tracheal intubation on the first attempt. An attempt is defined as the insertion and subsequent removal of the laryngoscopic device from the patient's mouth, regardless of whether an endotracheal tube was inserted.", 
                "measure": "First-pass success", 
                "safety_issue": "Yes", 
                "time_frame": "During the ED stay"
            }, 
            {
                "description": "The number of total attempts required to intubate each patient will be compared. One attempt is defined as the insertion and subsequent removal of the laryngoscopic device from the patient's mouth, regardless of whether an endotracheal tube was inserted.", 
                "measure": "Number of intubation attempts", 
                "safety_issue": "Yes", 
                "time_frame": "During the ED stay"
            }, 
            {
                "description": "The number of bolus doses of sedative administered post-intubation will be compared up to 6 hours (including morphine, dexmedetomidine, propofol , etomidate, ketamine, lorazepam (Ativan), midazolam (Versed), diazepam (Valium), fentanyl, hydromorphone (Dilaudid)). Infusions of these medications will be recorded separately but will not be part of this outcome.", 
                "measure": "Post-intubation sedation", 
                "safety_issue": "Yes", 
                "time_frame": "6 hours"
            }, 
            {
                "description": "The following will be compared between the two groups:\nHypoxemia and severe hypoxemia during and the 5 minutes immediately following intubation\nHypoxemia within the first 2 hours intubation\nHypoxemia is defined as SpO2 less than 90%. Severe hypoxemia is defined as SpO2 less than 90% for 60 seconds or more.", 
                "measure": "Post-intubation hypoxemia", 
                "safety_issue": "Yes", 
                "time_frame": "2 hours"
            }, 
            {
                "description": "The following will be compared between the two groups:\nHypotension in the ED post-intubation\nHypotension within the first 6 hours of the hospital stay\nHypotension is defined as a systolic blood pressure less than 90 mm Hg", 
                "measure": "Hypotension", 
                "safety_issue": "Yes", 
                "time_frame": "6 hours"
            }, 
            {
                "description": "Maximum SOFA score within three hospital days: all patients\nPre-defined subgroup: Maximum SOFA score within three hospital days: patients with sepsis", 
                "measure": "SOFA score", 
                "safety_issue": "Yes", 
                "time_frame": "3 days"
            }, 
            {
                "description": "The Peak and plateau pressures will be compared between the two groups, with a pre-defined subgroup analysis of patients who are being intubated for severe asthma and chronic obstructive pulmonary disease (COPD).", 
                "measure": "Peak and Plateau pressure", 
                "safety_issue": "Yes", 
                "time_frame": "ED stay"
            }
        ], 
        "source": "Minneapolis Medical Research Foundation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Minneapolis Medical Research Foundation", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}